5 March 2025
Latham & Watkins Advises Boston Scientific in Acquisition of SoniVie Ltd.
Advising firms
Deal team
29 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Julie Scallen Lead | Latham & Watkins LLP | Partner | corporate | Boston |
| Gilad Zohari Lead | Latham & Watkins LLP | Partner | corporate | Tel Aviv |
| Dante Spurlock | Latham & Watkins LLP | Associate | corporate | Not stated |
| Jamie Savren | Latham & Watkins LLP | Associate | corporate | Not stated |
| Edward Reynolds | Latham & Watkins LLP | Associate | corporate | Not stated |
| Nicholas DeNovio | Latham & Watkins LLP | Partner | tax | Washington, D.C. |
| Abigail Friedman | Latham & Watkins LLP | Associate | tax | Not stated |
| Nolon Blaylock | Latham & Watkins LLP | Associate | tax | Not stated |
| David Della Rocca | Latham & Watkins LLP | Partner | executive compensation and benefits | Washington, D.C. |
| Nikhil Kumar | Latham & Watkins LLP | Partner | executive compensation and benefits | Washington, D.C. |
| Christina Schrantz | Latham & Watkins LLP | Associate | executive compensation and benefits | Not stated |
| Nineveh Alkhas | Latham & Watkins LLP | Partner | labor and employment | Chicago |
| Imara Joroff | Latham & Watkins LLP | Associate | labor and employment | Not stated |
| Eliot Choy | Latham & Watkins LLP | Counsel | intellectual property | New York |
| Arun Mohan | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Patrick Chew | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy | Bay Area |
| Calum Docherty | Latham & Watkins LLP | Associate | data privacy | Not stated |
| Zac Alpert | Latham & Watkins LLP | Associate | data privacy | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare | Bay Area |
| Leia Gu | Latham & Watkins LLP | Associate | healthcare | Not stated |
| Margaret Rote | Latham & Watkins LLP | Associate | healthcare | Not stated |
| Chad Jennings | Latham & Watkins LLP | Counsel | FDA regulatory | Washington, D.C. |
| Eveline Van Keymeulen | Latham & Watkins LLP | Partner | EU regulatory | Paris |
| Jeanne Fabre | Latham & Watkins LLP | Associate | EU regulatory | Not stated |
| Raphaël Darmon | Latham & Watkins LLP | Counsel | French corporate | Paris |
| Yasmine Houichi | Latham & Watkins LLP | Associate | French corporate | Not stated |
| Xavier Renard | Latham & Watkins LLP | Partner | French tax | Paris |
| Camille Pons | Latham & Watkins LLP | Associate | French tax | Not stated |
26 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 360m (US$360 million)
- What the figure measures
- Total transaction value
- Client
- Boston Scientific CorporationBuy-side
- Counterparties
- SoniVie Ltd. (Sell-side)